Brief

The Drug Alert for November 2024, issued by CDSCO, identifies multiple Not of Standard Quality (NSQ) drugs, citing failures in sterility, assay, dissolution, particulate matter, and labeling violations. The report serves as a critical warning to healthcare professionals, pharmaceutical companies, and consumers, urging immediate action to remove non-compliant batches from circulation and reinforce quality control measures in drug manufacturing.

This content is restricted.

Highlights content goes here...

This content is restricted.

Central Drugs Standard Control Organization (CDSCO)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies